Evidence map›Paper›PMID 30930873›Full record

ReviewFrontiers in microbiology2019

Chronicle of a Soil Bacterium:

Haeyoung Jeong, Soo-Keun Choi, Choong-Min Ryu, Seung-Hwan Park

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
16.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Microorganisms · 2025
    Article
  9. Article
  10. Article
  11. Advancing sustainable practices withAIMS microbiology · 2025
    Review
  12. Article
  13. Review
  14. Unveiling a New Antimicrobial Peptide with Efficacy againstAntibiotics (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Isolation and Characterization ofInternational journal of molecular sciences · 2024
    Article
  19. Article
  20. Promising non-model microbial cell factories obtained by genome reduction.Frontiers in bioengineering and biotechnology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Haeyoung JeongInfectious Disease Research Center, KRIBB, Daejeon, South Korea.
Soo-Keun ChoiInfectious Disease Research Center, KRIBB, Daejeon, South Korea.
Choong-Min RyuInfectious Disease Research Center, KRIBB, Daejeon, South Korea.
Seung-Hwan ParkInfectious Disease Research Center, KRIBB, Daejeon, South Korea.
Korea University of Science and Technology · KRKorea Center for Disease Control and Prevention · KRKorea Research Institute of Bioscience and Biotechnology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Gram-positive rhizosphere bacterium

Indexed as

antimicrobial peptidesinduced systemic resistancenon-ribosomal peptide synthetasesPGPRpolyketidespolymyxin

Identifiers

PMID30930873
PMCPMC6429003
OpenAlexW2920923539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.